Whalen Wealth Management Inc. Immunome Inc. Transaction History
Whalen Wealth Management Inc.
- $159 Billion
- Q2 2025
A detailed history of Whalen Wealth Management Inc. transactions in Immunome Inc. stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 13,722 shares of IMNM stock, worth $132,966. This represents 0.08% of its overall portfolio holdings.
Number of Shares
13,722Holding current value
$132,966% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
157Shares Held
69.2MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$73.2 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$51.9 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$42.3 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$41.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$39.5 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $118M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...